Skip to main content

Advertisement

SpringerLink
Log in

Tea: age-old beverage as an effective cancer chemopreventive agent

  • Review
  • Published:
Oncology Reviews

Abstract

Cancer is the major public health problem, causing approximately 7 million deaths every year worldwide. The existing treatment approaches and surgical techniques have not been able to cope effectively with this dreaded disease. Because of this, the concept of chemoprevention is now considered a valid approach to reduce the incidence of cancer. There is convincing epidemiological and experimental evidence to show that dietary polyphenolic plant-derived compounds have cancer preventive properties. Based on evidence from in vitro, in vivo data and epidemiological studies, tea has received considerable attention over recent years for reducing the risk of several cancers. Much of the cancer preventive effects of tea, and in particular green tea, appear to be mediated by the polyphenols they contain. In addition to inhibiting mutagenesis and proliferation, tea is relatively non-toxic, is low cost, and can be taken orally or as a part of the daily diet. Therefore it is logical that future clinical studies should focus on examining the efficacy of tea and its active constituents, such as epigallocatechin-3-gallate (EGCG) and theaflavins (TFs), in chemoprevention as an alternative to pharmacological agents. In this review, we address the use of tea and its constituents for the prevention and treatment of cancer. Further mechanistic and dose-response studies will help us to understand the effects of tea consumption on human carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Watson W, Cai J, Jones D (2000) Diet and apoptosis. Annu Rev Nutr 108:153–164

    Google Scholar 

  2. Wenzel U, Kuntz S, Brendel M, Daniel H (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60:3823–3831

    PubMed  CAS  Google Scholar 

  3. Yang C, Landau J, Huang M, Newmark H (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381–397

    Article  PubMed  CAS  Google Scholar 

  4. Sporn MB, Suh N (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2:537–543

    Article  PubMed  CAS  Google Scholar 

  5. Khan N, Mukhtar H (2007) Tea polyphenols for health promotion. Life Sci 81:519–533

    Article  PubMed  CAS  Google Scholar 

  6. Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37:693–704

    PubMed  CAS  Google Scholar 

  7. Stoner GD, Mukhtar H (1995) Polyphenols as cancer chemopreventive agents. J Cell Biochem 22:169–180

    Article  CAS  Google Scholar 

  8. Mukhtar H, Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71:1698S–1702S

    PubMed  CAS  Google Scholar 

  9. Yang CS, Wang ZY (1993) Tea and cancer. J Natl Cancer Inst 85:1038–1049

    Article  PubMed  CAS  Google Scholar 

  10. Katiyar SK (2003) Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr Drug Targets Immune Endocr Metabol Disord 3:234–242

    Article  PubMed  CAS  Google Scholar 

  11. Yang CS, Lee MJ, Chen L, Yang GY (1997) Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect 105:971–976

    Article  PubMed  CAS  Google Scholar 

  12. Khan N, Afaq F, Saleem M et al (2006) Targeting multiple signaling pathways by green tea polyphenol (-) — epigallocatechin-3-gallate. Cancer Res 66:2500–2505

    Article  PubMed  CAS  Google Scholar 

  13. Wiseman SA, Balentine DA, Frei B (1997) Antioxidants in tea. Crit Rev Food Sci Nutr 37:705–718

    Article  PubMed  CAS  Google Scholar 

  14. Goldbohm R, Hertog M, Brants H et al (1996) Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88:93–100

    Article  PubMed  CAS  Google Scholar 

  15. Tsubono Y, Nishino Y, Komatsu S et al (2001) Green tea and the risk of gastric cancer in Japan. N Engl J Med 344:632–636

    Article  PubMed  CAS  Google Scholar 

  16. Tsubono Y, Tsugane S, Gey KF (1999) Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer 34:56–61

    Article  PubMed  CAS  Google Scholar 

  17. Arts I, Holmann P, Bueno de Mesquita H et al (2001) Dietary catechins and epithelial cancer incidence: the Zutphen Elderly Study. Int J Cancer 92:298–302

    Article  PubMed  CAS  Google Scholar 

  18. Garcia-Closas R, Agudo A, Gonzalez C, Riboli E (1998) Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 32:154–158

    Article  PubMed  CAS  Google Scholar 

  19. Arts I, Jacobs Jr D, Gross M et al (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s Health Study (United States). Cancer Causes Control 13:373–382

    Article  PubMed  Google Scholar 

  20. De Stefani E, Roncoa A, Mendilaharsu M, Deneo-Pellegrini H (1999) Diet and risk of cancer of the upper aerodigestive tract: II. Nutrients. Oral Oncol 35:22–26

    Article  Google Scholar 

  21. Garcia-Closas R, Gonzalez C, Agudo A, Riboli E (1999) Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10:71–75

    Article  PubMed  CAS  Google Scholar 

  22. Su L, Arab L (2002) Tea consumption and the reduced risk of colon cancer — results from a national prospective cohort study. Public Health Nutr 5:419–425

    Article  PubMed  Google Scholar 

  23. Le Marchand L, Murphy S, Hankin J et al (2000) Intake of flavonoids and lung cancer. J Natl Cancer Inst 92:154–160

    Article  PubMed  Google Scholar 

  24. Nakachi K, Suemasu K, Suga K et al (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89:254–261

    PubMed  CAS  Google Scholar 

  25. Lambert JD, Yang CS (2003a) Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 523–524:201–208

    PubMed  Google Scholar 

  26. Lambert JD, Yang CS (2003b) Mechanisms of cancer prevention by tea constituents. J Nut 133:3262S–3267S

    CAS  Google Scholar 

  27. Jian L, Xie LP, Lee AH, Binns CW (2004) Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 108:130–135

    Article  PubMed  CAS  Google Scholar 

  28. Sueoka N, Suganuma M, Sueoka E et al (2001) A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci 928:274–280

    Article  PubMed  CAS  Google Scholar 

  29. Katiyar SK, Elmets CA (2001) Green tea polyphenolic antioxidants and skin photoprotection. Int J Oncol 18:1307–1313

    PubMed  CAS  Google Scholar 

  30. SK Mantena, SM Meeran, CA Elmets, SK Katiyar (2005) Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J Nutr 135:2871–2877

    PubMed  CAS  Google Scholar 

  31. Javed S, Mehrotra NK, Shukla Y (1998) Chemopreventive effects of black tea polyphenols in mouse skin model of carcinogenesis. Biomed Environ Sci 11307–11313

  32. Katiyar SK, Afaq F, Perez A, Mukhtar H (2001) Green tea polyphenol (-) — epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22:287–294

    Article  PubMed  CAS  Google Scholar 

  33. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H (2001) Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-) — epigallocatechin-3-gallate. Toxicol Appl Pharmacol 176:101–107

    Article  CAS  Google Scholar 

  34. Afaq F, Adhami VM, Ahmad N, Mukhtar H (2003) Green tea constituent (-) — epigallocatechin-3-gallate inhibits ultraviolet B-mediated activation of nuclear factor kappa B signaling pathway in normal human epidermal keratinocytes. Oncogene 22:1035–1044

    Article  PubMed  CAS  Google Scholar 

  35. Hakim IA, Harris RB (2001) Joint effects of citrus peel use and black tea intake on the risk of squamous cell carcinoma of the skin. BMC Dermatology 1:3

    Article  PubMed  CAS  Google Scholar 

  36. Kalra N, Prasad S, Shukla Y (2005) Antioxidant potential of black tea against 7,12-dimethylbenz(a) anthracene-induced oxidative stress in Swiss albino mice. J Environ Pathol Toxicol Oncol 24:105–114

    Article  PubMed  CAS  Google Scholar 

  37. Nakachi K, Matusuyama S, Miyake S et al (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49–54

    PubMed  CAS  Google Scholar 

  38. Sozzi G, Miozzo M, Donghi R et al (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079–6082

    PubMed  CAS  Google Scholar 

  39. Xu Y, Ho CT, Amin SG et al (1992) Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 52:3875–3879

    PubMed  CAS  Google Scholar 

  40. Wang ZY, Agarwal R, Khan WA, Mukhtar H (1992) Protection against benzo[a]pyrene-and N-nitrosodiethy-lamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis 13:1491–1494

    Article  PubMed  CAS  Google Scholar 

  41. Wang ZY, Huang MT, Ho CT et al (1992) Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 52:6657–6665

    PubMed  CAS  Google Scholar 

  42. Xu Y, Ho CT, Amin SG et al (1992) Inhibition of tobacco specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Research 52:3875–3879

    PubMed  CAS  Google Scholar 

  43. Liao J, Yang GY, Park ES et al (2004) Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 48:44–53

    Article  PubMed  Google Scholar 

  44. Landau JM, Wang ZY, Yang GY et al (1998) Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis 19:501–507

    Article  PubMed  CAS  Google Scholar 

  45. Shay J, Wright W (2006) Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Disc 5:577–584

    Article  CAS  Google Scholar 

  46. Sadava D, Whitlock E, Kane SE (2007) The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun 360:233–237

    Article  PubMed  CAS  Google Scholar 

  47. Banerjee S, Manna S, Saha P (2005) Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo (a)pyrene-induced lung carcinogenesis. European Journal of Cancer Prevention 14:215–221

    Article  PubMed  CAS  Google Scholar 

  48. Parkin D, Muir C (1992) Cancer incidence in five continents: comparability and quality of data. IARC Sci Publ 120:45–173

    PubMed  Google Scholar 

  49. Leung LK, Su Y, Chen R et al (2001) Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 131:2248–2251

    PubMed  CAS  Google Scholar 

  50. Chen CW, Ho CT (1995) Antioxidant properties of polyphenols extracted from green and black teas. J Food Lipids 2:35–46

    Article  CAS  Google Scholar 

  51. Pryor WA (1986) Cancer and free radicals. Basic Life Sci 39:45–59

    PubMed  CAS  Google Scholar 

  52. Bartsch H, Nair J (2004) Oxidative stress and lipid peroxidation derived DNA lesions in inflammation driven carcinogenesis. Cancer Detect PreV 28:385–391

    Article  PubMed  CAS  Google Scholar 

  53. Wu AH, Yu MC, Tseng CC et al (2003) Green tea and risk of breast cancer in asian americans. Int J Cancer 106:574–579

    Article  PubMed  CAS  Google Scholar 

  54. Zhou JR, Yu L, Mai Z, Blackburn GL (2004) Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 108:8–14

    Article  PubMed  CAS  Google Scholar 

  55. Rogers AE, Hafer LJ, Iskander YS, Yang CS (1998) Black tea and mammary gland carcinogenesis by 7, 12-dimethylbenz-[a]anthracene in rats fed control or high fat diets. Carcinogenesis 19:1269–1273

    Article  PubMed  CAS  Google Scholar 

  56. Weisburger JH, Rivenson A, Garr K, Aliaga C (1997) Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett 114:323–327

    Article  PubMed  CAS  Google Scholar 

  57. Green JE, Shibata MA, Yoshidome K et al (2000) The C3 (1)/SV40 T antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19:1020–1027

    Article  PubMed  CAS  Google Scholar 

  58. Leong H, Mathur PS, Greene GL (2008) Inhibition of mammary tumorigenesis in the C3 (1)/SV40 mouse model by green tea. Breast Cancer Res Treat 107:359–369

    Article  PubMed  CAS  Google Scholar 

  59. Baliga MS, Meleth S, Katiyar SK (2005) Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res 11:1918–1927

    Article  PubMed  CAS  Google Scholar 

  60. Thangapazham RL, Passi N, Maheshwari RK (2007) Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast Cancer Cells. Cancer Biol Ther 6

  61. Klein EA (2005) Can prostate cancer be prevented? Nat Clin Pract Urol 2:24–31

    Article  PubMed  Google Scholar 

  62. Sonn GA, Aronson W, Litwin MS (2005) Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 8:304–310

    Article  PubMed  CAS  Google Scholar 

  63. Ahmad N, Feyes DK, Nieminen AL (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89:1881–1886

    Article  PubMed  CAS  Google Scholar 

  64. Paschka AG, Butler R, Young CY (1998) Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130:1–7

    Article  PubMed  CAS  Google Scholar 

  65. Lyn-cook BD, Rogers T, Yan Y et al (1999) Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 35:80–86

    Article  PubMed  CAS  Google Scholar 

  66. Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096–4102

    PubMed  CAS  Google Scholar 

  67. Gingrich JR, Barrios RJ, Kattan MW et al (1997) Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57:4687–4691

    PubMed  CAS  Google Scholar 

  68. Gupta S, Hastak K, Ahmad N et al (2001) Inhibition of prostate carcinogenesis in TRAMP mice by I oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98:10350–10355

    Article  PubMed  CAS  Google Scholar 

  69. Koivisto P, Visakorpi T, Rantala I, Isola J (1997) Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer. J Pathol 183:51–56

    Article  PubMed  CAS  Google Scholar 

  70. Koivisto P, Hyytinen E, Palmberg C et al (1995) Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy. Am J Pathol 147:1608–1614

    PubMed  CAS  Google Scholar 

  71. Taplin ME, Bubley GJ, Shuster TD et al (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393–1398

    Article  PubMed  CAS  Google Scholar 

  72. Kao YH, Hiipakka RA, Liao S (2000) Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141:980–987

    Article  PubMed  CAS  Google Scholar 

  73. Webber MM, Waghray A, Bello D (1995) Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1:1089–1094

    PubMed  CAS  Google Scholar 

  74. Di Silverio F, Sciarra A, Monti S et al (1999) Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia? J Urol 161:128–132

    Article  PubMed  Google Scholar 

  75. Pezzato E, Sartor L, Dell’Aica I et al (2004) Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-) epigallocatechin-3-gallate. Int J Cancer 112:787–792

    Article  PubMed  CAS  Google Scholar 

  76. Kalra N, Seth K, Prasad S et al (2007) Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways. Life Sci 80:2137–2146

    Article  PubMed  CAS  Google Scholar 

  77. Lee JS, Chu IS, Heo J et al (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40:667–676

    Article  PubMed  CAS  Google Scholar 

  78. Gong Y, Han C, Chen J (2000) Effect of tea polyphenols and tea pigments on the inhibition of precancerous liver lesions in rats. Nutr Cancer 38:81–86

    Article  PubMed  CAS  Google Scholar 

  79. Nishikawa T, Nakajima T, Moriguchi M et al (2006) A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 44:1074–1082

    Article  PubMed  CAS  Google Scholar 

  80. Gong Y, Han C, Chen J (1999) Inhibitory effects of tea polyphenols and tea pigments on liver precancerous lesions in rats. Wei Sheng Yan Jiu 28:294–296

    PubMed  CAS  Google Scholar 

  81. Mu LN, Zhou XF, Ding BG et al (2003) A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi 24:192–195

    PubMed  Google Scholar 

  82. Oguni I, Chen SJ, Lin PZ, Hara Y (1992) Protection against cancer risk by Japanese green tea. Prevent Med 21:332

    Google Scholar 

  83. Wang ZY, Hong JY, Huang MT et al (1992) Inhibition of N-nitrosodiethylamine and 4-(methylnitrosamino)-1 — (3-pridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52:1943–1947

    PubMed  CAS  Google Scholar 

  84. Yamane T, Nakatani H, Kikuoka N (1996) Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 77:1662–1667

    PubMed  CAS  Google Scholar 

  85. Suganuma M, Ohkura Y, Okabe S, Fujiki H (2001) Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol 127:69–72

    Article  PubMed  CAS  Google Scholar 

  86. Caderni G, De Filippo C, Luceri C (2000) Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21:1965–1969

    Article  PubMed  CAS  Google Scholar 

  87. Wang M, Guo C, Li M (1999) A case-control study on the dietary risk factors of upper digestive tract cancer. Zhonghua Liu Xing Bing Xue Za Zhi 20:95–97

    PubMed  CAS  Google Scholar 

  88. Ju J, Hong J, Zhou JN (2005) Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65:10623–10631

    Article  PubMed  CAS  Google Scholar 

  89. Shimizu M, Deguchi A, Lim JT et al (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11:2735–2746

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Proteomics Laboratory, Industrial Toxicology Research Centre, Mahatma Gandhi Marg, Lucknow, 226001, India

    Yogeshwer Shukla

Authors
  1. Jasmine George
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nidhi Nigam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yogeshwer Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yogeshwer Shukla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

George, J., Nigam, N. & Shukla, Y. Tea: age-old beverage as an effective cancer chemopreventive agent. Oncol Rev 1, 243–252 (2008). https://doi.org/10.1007/s12156-008-0029-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12156-008-0029-5

Key words

Search

Navigation